http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0462884-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 1991-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1993-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0462884-B1 |
| titleOfInvention | Trh derivatives, their preparations and pharmaceutical compositions containing them |
| abstract | The invention relates to compounds of formula (I): <IMAGE> (I) in which: A represents, with the carbon and nitrogen atoms to which it is linked, cyclic amide as defined in the description, B represents, with the nitrogen and carbon atoms to which it is linked, saturated polycyclic structure as defined in the description, R represents hydrogen, optionally substituted lower alkyl, optionally substituted (4-imidazolyl)methyl, (3-pyrazolyl)methyl or optionally substituted (2-pyridyl)methyl, their enantiomers, diastereoisomers and epimers as well as their addition salts with a pharmaceutically acceptable acid. Medicinal products. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7498341-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7223796-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7262220-B2 |
| priorityDate | 1990-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.